Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

If the secretary of Health and Human Services truly wants to solve America’s obesity crisis, he must understand that ...

A new study from Northwestern University has found that two widely prescribed type 2 diabetes medications—sulfonylureas and ...

Despite the promising results, further research is needed before GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists ...

Tv Therapeutics' Phase 3 trial for cadisegliatin in type 1 diabetes resumes after FDA lifts hold, with a revised six-month ...

The Oklahoma Poison Center is reporting a “surge” of incoming calls about accidental overdosing of popular injectable drugs used for weight loss and diabetes management. Called GLP-1 agonists and used ...

Inositol supplements show significant benefits for hormonal disorders, insulin sensitivity, and fertility issues, offering a ...

WEIGHT loss jabs have become the latest fad for changing your appearance. It seems as though half of Hollywood is using ...

For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...

The Affordable Insulin Now Act, as it is known ... Unfortunately, the current drug pricing bill fails to take a holistic approach to addressing a system that drives affordability challenges ...

A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome ...

Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes. CATT1 Phase 3 trial expected to ...